ORAP TAB 10MG DIN 00573817
Status: Cancelled Post Market
Holder: MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC.
Molecule: PIMOZIDE
Health Canada record
| Active ingredient(s) | PIMOZIDE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AG02 PIMOZIDE |
| Original market date | 31-Dec-1983 |
| Current status date | 19-Aug-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PIMOZIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02245432 | PIMOZIDE | AA PHARMA INC | Tablet | PIMOZIDE 2 MG | Marketed |
| 02245433 | PIMOZIDE | AA PHARMA INC | Tablet | PIMOZIDE 4 MG | Marketed |
| 00313823 | ORAP | AA PHARMA INC | Tablet | PIMOZIDE 4 MG | Dormant |
| 00313815 | ORAP | AA PHARMA INC | Tablet | PIMOZIDE 2 MG | Dormant |
| 02239830 | PMS-PIMOZIDE | PHARMASCIENCE INC | Tablet | PIMOZIDE 4 MG | Cancelled Post Market |
| 02239829 | PMS-PIMOZIDE | PHARMASCIENCE INC | Tablet | PIMOZIDE 2 MG | Cancelled Post Market |
| 02239831 | PMS-PIMOZIDE | PHARMASCIENCE INC | Tablet | PIMOZIDE 10 MG | Cancelled Pre Market |
International API supply for PIMOZIDE
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for ORAP TAB 10MG